Common in Biological Technology

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

EMERYVILLE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has agreed to sell an aggregate of four million shares of its common stock at a price to the public of $30.50 per share and $200 million aggregate principal amou...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

CAMBRIDGE, Mass., Aug. 5 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of...

Micromet Closes $80.5 Million Public Offering of Common Stock

BETHESDA, Md., Aug. 4, /PRNewswire-FirstCall/ --Micromet, Inc. (Nasdaq: MITI ) ("Micromet" or the "Company"), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the closing of its previ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it has closed on the issuance of 2-year, 10% unsecured ...

Micromet Announces Pricing of Public Offering of Common Stock

BETHESDA, Md., July 30 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the pricing of its public offering of 14,000,000 shares of...

Micromet Announces Public Offering of Common Stock

BETHESDA, Md., July 29 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it intends to offer shares of its common st...

Human Genome Sciences Announces Pricing of Public Offering of Common Stock

ROCKVILLE, Md., July 28 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced the pricing of its underwritten public offering of 23,215,000 newly issued shares of its common stock at a price to the public of $14.00 per share. The size of the offering was inc...

Human Genome Sciences Announces Proposed Public Offering of Common Stock

ROCKVILLE, Md., July 27 /PRNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced that it has commenced an underwritten public offering of up to 18,000,000 shares of its common stock. The Company intends to grant the underwriters a 30-day option to purchase up to an add...

Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

SEATTLE, July 23 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) ("CTI" or the "Company") today announced the pricing of an underwritten public offering of 29,332,107 shares of its common stock and warrants to purchase up to 7,333,027 shares of its common st...

OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock

BOTHELL, WA and VANCOUVER, July 20 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today it has entered into purchase agreements with certain institutional investors for the sale of 475,000 shares of its common stock at a price of $20 per share through a regist...

Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders

CHENGDU, China, July 8 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI ), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today declared a quarterly cash dividend to be paid to its common stock sharehold...

Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock

KENILWORTH, N.J., June 23 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP ) today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Aug. 31, 2009, to shareholders of record at the close of business on August 7, 2009. ...

Wyeth Declares Common Stock Dividend

MADISON, N.J., June 11 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors, held today, Wyeth (NYSE: WYE ) declared a dividend on the Common Stock of the Company. A dividend of thirty cents ($.30) per share on the outstanding shares of Common Stock was declared payable on Sep...

GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants

GAITHERSBURG, Md., May 28 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) announced today that it has entered into a purchase agreement with a single institutional investor for the sale of 9,615,385 shares of its common stock and warrants to purchase 9,615,385 shares of its common stock...

Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings

FRAZER, Pa., May 21 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today the pricing of its concurrent public offerings of 5 million shares of common stock, at a price of $60 per share, and $435 million in aggregate principal amount of 2.50% convertible senior subordinated no...

Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes

FRAZER, Pa., May 20 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today that it intends to offer, subject to market and other conditions, $300 million of common stock and $350 million in aggregate principal amount of convertible senior subordinated notes due 2014 through t...

Beckman Coulter, Inc. Announces Pricing of Common Stock Offering

ORANGE COUNTY, Calif., May 20 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, today announced that it priced a public offering of shares of its common stock, ...

Dendreon Announces Closing of Common Stock Offering

SEATTLE, May 13 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) announced today the closing of its previously reported underwritten public offering of 10,700,000 shares of its common stock, which shares were offered for sale to the public at $19.20 per share. On May 8, 2009, Deut...

Dendreon Announces Common Stock Offering

SEATTLE, May 8 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) announced today the pricing of an underwritten public offering of 10,700,000 shares of its common stock. Deutsche Bank Securities will act as sole manager for the offering. Dendreon has granted Deutsche Bank Securiti...

Advanced Life Sciences Common Stock Begins Trading on OTC Bulletin Board

- Company to Host 2009 First Quarter Financial Results Conference Call and Webcast - CHICAGO, May 6 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. announced today that its common stock is eligible for quotation and trading on the Over-the-Counter Bulletin Board (OTCBB) under ...

Arno Therapeutics to Deregister its Common Stock under the Exchange Act

PARSIPPANY, N.J., May 4 /PRNewswire-FirstCall/ -- Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced that it has voluntarily filed a Form 15 with the Securities and Exchange Commission ("SEC") in order to...

Wyeth Declares Common and Preferred Stock Dividends

MADISON, N.J., April 23 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors, held today, Wyeth (NYSE: WYE ) declared dividends on both the Common and Preferred Stock of the Company. A dividend of thirty cents ($.30) per share on the outstanding shares of Common Stock was decl...

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock

PASADENA, Calif., March 19 /PRNewswire-FirstCall/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE ) announced today the pricing of its follow-on public offering of 7,000,000 shares of common stock at a price of $38.25 per share, upsized from an originally sized offering of 4,500,000 shares. ...

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock

MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into agreements with the current holders of its Series B Preferred Stock, $0.01 par value per share, under which $2,875,000 in accrued dividend obligations r...

InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock

BRISBANE, Calif., Feb. 13 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock. The last reported sale price of InterMune's common stock on the NASDAQ Global Select Market on February 12,...

deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market

REYKJAVIK, Iceland, February 3 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN ) announced that on February 2, 2009, it received a letter from the Nasdaq Listing Qualifications Panel (the "Panel") stating that the Panel will transfer the listing of deCODE's common stock from the Nasda...

Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock

PRINCETON, N.J., Jan. 30 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announced today that it has entered into definitive agreements dated January 29, 2009 with a select group of institutional investors to sell 4,678,000 shares of its common stock in a "registered direct" offering....

Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma

SAN CARLOS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO ) today announced that the stockholders of Nuvelo have approved the issuance of Nuvelo Common Stock pursuant to the merger agreement dated September 24, 2008, as amended, between Nuvelo, ARCA biopharma and a Nuve...

deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis

REYKJAVIK, Iceland, December 15 /PRNewswire-FirstCall/ -- - Findings Point to Potential Therapeutic Pathways and Provide Widening Basis for the Development of a Risk Assessment Test Scientists from deCODE genetics (Nasdaq: DCGN ) and colleagues from Australia and Denmark today rep...

BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends

SAN DIEGO, Dec. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR ) today announced that its board of directors has declared a fourth quarter 2008 dividend of $0.335 per share of common stock. The dividend is equivalent to an annualized dividend of $1.34 per common share. ...

Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock

KENILWORTH, N.J., Dec. 10 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP ) today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Feb. 27, 2009, to shareholders of record at the close of business on Feb. 6, 2009. A...

PLC Systems Expects Common Stock To Be Delisted From American Stock Exchange

FRANKLIN, Mass., Oct. 17 /PRNewswire-FirstCall/ -- PLC Systems Inc. (AMEX: PLC ) today announced that it has not submitted a plan to the American Stock Exchange that would demonstrate its ability to regain compliance with the Exchange's listing standards. Accordingly, the company anticipates ...

deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer

Latest discoveries add to understanding of individual risk of basal cell carcinoma, and are integrated into the deCODEme(TM) personal genome analysis scan REYKJAVIK, Iceland, Oct. 13 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN ) today report the discovery of common...

Wyeth Announces Increase in Common Stock Dividend

MADISON, N.J., Sept. 25 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors, held today, Wyeth (NYSE: WYE ) declared an increase in its common stock dividend. A dividend of thirty cents ($0.30) per share on the outstanding shares of common stock was declared payable on December...

BioMed Realty Trust Declares Third Quarter 2008 Common Stock and Preferred Stock Dividends

SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR ) today announced that its board of directors has declared a third quarter 2008 dividend of $0.335 per share of common stock. The dividend is equivalent to an annualized dividend of $1.34 per common share. Bi...

Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering

CORAL GABLES, Fla., Sept. 12 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ), a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today a...

Video: CSL Behring Provides $1.2M Grant for World's First Study of Postpartum Women with VWD, Common Bleeding Disorder

Goal is to determine whether therapy after childbirth for women with von Willebrand disease is needed and for how long KING OF PRUSSIA, Pa., Aug. 18 /PRNewswire/ -- CSL Behring is providing a $1.2 million grant to fund a first-of-its kind, nationwide study that when completed could...

Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants

ROCKVILLE, Md., July 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today announced the pricing of a registered direct equity financing of $18 million by issuing common stock and warrants from its existing shelf registration. The Company has entered into subscription agreements wi...

Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases

SEATTLE, July 17 /PRNewswire/ -- Researchers at Fred Hutchinson Cancer Research Center have received a $7.6 million, four-year grant from the National Human Genome Research Institute to better understand the genetic and biological roots of common diseases. The Hutchinson Center is one of four ...

Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock

PRINCETON, N.J., July 15 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announced today that it has entered into definitive agreements dated July 14, 2008 with a select group of institutional investors to sell 1,450,000 shares of its common stock in a "registered direct" offering....